Skip to main content
. 2021 Apr 12;95(9):e02165-20. doi: 10.1128/JVI.02165-20

FIG 4.

FIG 4

Plasma HIV viral load and CD4+ T-cell count changes throughout the study. (A) Levels of plasma HIV RNA in the placebo (red) and therapeutic vaccine (blue) groups before and after ATI (weeks 36 to 48); (B) CD4+ T-cell count changes during the vaccination phase and following ATI in the placebo (red) and therapeutic vaccine (blue) groups before and after ATI (weeks 36 to 48).